Judge OKs Class In Dendreon Securities Suit
A federal judge has granted class certification to investors that sued Dendreon Corp. for allegedly deceiving them about the approval process for the biotechnology company's prostate cancer drug Provenge....To view the full article, register now.
Already a subscriber? Click here to view full article